en

PRODUCT DETAIL

Ocrevus 300 mg infúzny koncentrát

Code 6794C
MA number EU/1/17/1231/001
Product Form: con inf 1x10 ml/300 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA36 Ocrelizumab
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 08.01.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.10.2022
eu-flag.png sk-flag.png